secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPECTRUM PHARMACEUTICALS INC (—)
CIK:        0000831547
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0000831547-22-000065
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Spectrum Pharma receives Nasdaq bid price deficiency notice; 180 days to cure
-----------------------------------------------------------------------------

- Nasdaq notified Spectrum on Nov 2, 2022 that bid price below $1.00 for 30 days, violating Minimum Bid Price Rule.
- Company has 180 calendar days, until May 2, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured by May 2, 2023, Spectrum may apply for transfer to Nasdaq Capital Market for additional 180-day period.
- No immediate effect on listing; Spectrum intends to monitor and consider options, but no decision made yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/831547/000083154722000065/0000831547-22-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/831547/000083154722000065/sppi-20221102.htm
  HTML page:      https://secwatch.observer/filing/0000831547-22-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer